Sofinnova Investments, Inc. Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001631134

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidFocusedHealth TiltHigh Turnover how tags are computed

Q4 2023 · 59 positions · Total reported value $1.75B · Top-10 concentration 66.5% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 67.1% · 13 new · 16 cut · 26 exited

Active Share (vs S&P 500): 99.1% · vs QQQ: 98.7% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q1 2026 → Q2 2026): +12.4% · vs SPY -2.4% · Prev Value $2.38B — last quarter positions weighted by this quarter price moves · ranking

In its Q4 2023 13F filing, Sofinnova Investments, Inc. disclosed 59 equity positions with a combined reported value of $1.75B. The filing implies a focused portfolio: its ten largest positions account for 66.5% of reported value. HoldingsHub classifies the profile as Mid / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q4 2023 were KRTX ($437.15M), RYZB ($150.42M), NTRA ($97.11M). By sector, the heaviest allocations are Health Care 53.4%, Consumer Discretionary 1.5%. Versus the prior quarter, allocation shifted toward Other (+11.5pp) and away from Consumer Discretionary (-1.0pp), Health Care (-10.5pp).

Versus the prior quarter, Sofinnova Investments, Inc. opened 13 new positions, trimmed 16 and fully exited 26, a turnover rate of 67.1% of positions. The portfolio's overlap with the prior quarter was 61% of names.

The largest new positions opened in Q4 2023 were LLY ($37.61M), KURA ($23.98M), INCY ($18.62M).

Of the 26 positions fully exited versus the prior quarter, the largest were IWM ($39.77M), IDXX ($34.06M), ZNTL ($24.31M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q4 2023)

  • LLY ELI LILLY & CO · $37.61M
  • KURA KURA ONCOLOGY INC · $23.98M
  • INCY INCYTE CORP · $18.62M
  • PHVS PHARVARIS N V · $14.32M
  • CABA CABALETTA BIO INC · $9.75M
  • BSX BOSTON SCIENTIFIC CORP · $7.57M
  • PODD INSULET CORP · $4.12M
  • IRWD IRONWOOD PHARMACEUTICALS INC · $3.79M

Fully Exited (vs previous quarter)

  • IWM ISHARES TR · prev qtr: $39.77M
  • IDXX IDEXX LABS INC · prev qtr: $34.06M
  • ZNTL ZENTALIS PHARMACEUTICALS INC · prev qtr: $24.31M
  • SPY STATE STR SPDR S&P 500 ETF T · prev qtr: $21.37M
  • EXEL EXELIXIS INC · prev qtr: $18.15M · history
  • QQQ INVESCO QQQ TR · prev qtr: $17.91M
  • ALKS ALKERMES PLC · prev qtr: $15.05M
  • CRSP CRISPR THERAPEUTICS AG · prev qtr: $9.08M

Insider Transactions (Form 4)

Latest Sofinnova Investments, Inc. buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Sofinnova Investments, Inc., based in Menlo Park, CA, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 56 positions worth $1.88B in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: MENLO PARK, CA, United States
  • SEC registration: 801-110134 (status: Approved), registered 2017-03-22
  • Regulatory AUM (Form ADV): $5.37B as of 2026-03-27
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 7 private funds, of which 3 hedge funds
  • Website: sofinnova.com

Portfolio Structure

  • 56 positions · $1.88B reported value (Q2 2026)
  • Top 10 holdings = 59.2% of reported value
  • Largest position: NTRA (NATERA INC) at 22.4%
  • Average position size: $33.52M

Sector Tilt

  • Health Care 100.0%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 13 new, 14 added, 16 reduced, 26 exited
  • 13 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 53.4%
Other 45.1%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 1.38M $437.15M 24.92%
24.92%
Hold
2 2.42M $150.42M 8.58%
8.58%
Hold
3 1.55M $97.11M 5.54%
5.54%
Reduce
4 754.03K $94.97M 5.42%
5.42%
Hold
5 857.97K $93.54M 5.33%
5.33%
Add
6 3.76M $85.06M 4.85%
4.85%
Hold
7 850.58K $57.29M 3.27%
3.27%
Reduce
8 3.47M $53.32M 3.04%
3.04%
Hold
9 1.46M $51.91M 2.96%
2.96%
Add
10 1.55M $45.87M 2.62%
2.62%
Reduce
11 126.96K $42.83M 2.44%
2.44%
Reduce
12 64.53K $37.61M 2.14%
2.14%
New
13 414.21K $34.58M 1.97%
1.97%
Reduce
14 844.01K $33.47M 1.91%
1.91%
Add
15 1.41M $33.35M 1.90%
1.90%
Add
16 2.97M $31.26M 1.78%
1.78%
Reduce
17 598.98K $29.79M 1.70%
1.70%
Reduce
18 772.96K $29.37M 1.68%
1.68%
Add
19 1.21M $25.99M 1.48%
1.48%
Reduce
20 1.67M $23.98M 1.37%
1.37%
New
21 1.08M $23.25M 1.32%
1.32%
Add
22 62.79K $18.80M 1.07%
1.07%
Add
23 296.57K $18.62M 1.06%
1.06%
New
24 8.81M $18.60M 1.06%
1.06%
Add
25 4.28M $18.23M 1.04%
1.04%
Hold
26 1.19M $17.79M 1.01%
1.01%
Reduce
27 44.72K $17.01M 0.97%
0.97%
Reduce
28 2.19M $14.96M 0.85%
0.85%
Hold
29 510.44K $14.32M 0.82%
0.82%
New
30 1.01M $13.48M 0.77%
0.77%
Add
31 2.38M $11.20M 0.64%
0.64%
Add
32 352.40K $10.40M 0.59%
0.59%
Add
33 429.39K $9.75M 0.56%
0.56%
New
34 222.55K $9.38M 0.54%
0.54%
Add
35 131.00K $7.57M 0.43%
0.43%
New
36 174.84K $7.13M 0.41%
0.41%
Reduce
37 113.76K $6.87M 0.39%
0.39%
Reduce
38 19.00K $4.12M 0.23%
0.23%
New
39 331.10K $3.79M 0.22%
0.22%
New
40 2.75M $3.08M 0.18%
0.18%
Hold
41 2.67M $3.05M 0.17%
0.17%
Hold
42 20.00K $2.48M 0.14%
0.14%
Reduce
43 4.00K $1.51M 0.09%
0.09%
New
44 12.80K $1.50M 0.09%
0.09%
New
45 1.60M $1.32M 0.08%
0.08%
Hold
46 125.30K $1.20M 0.07%
0.07%
Add
47 100.00K $1.09M 0.06%
0.06%
Reduce
48 318.37K $929.65K 0.05%
0.05%
Hold
49 363.48K $716.05K 0.04%
0.04%
Add
50 2.40M $709.92K 0.04%
0.04%
Hold

FAQ

What did Sofinnova Investments, Inc. buy in 2023-Q4?

In its 2023-Q4 13F filing, Sofinnova Investments, Inc. reported 59 equity positions worth $1.75B in aggregate; its largest disclosed positions were KRTX ($437.15M), RYZB ($150.42M), NTRA ($97.11M).

How large is Sofinnova Investments, Inc.'s portfolio?

Sofinnova Investments, Inc. reported $1.75B of long equity holdings across 59 positions as of 2023-Q4. Top-10 holdings account for 66.5% of reported value.

What is Sofinnova Investments, Inc.'s investment style?

HoldingsHub classifies the portfolio as Mid / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/sofinnova-investments/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →